Enterovirus Related Myopathy in a Subset of Chronic Fatigue Syndromeq?

References

• Brooks GF, Butel JS, Morse SA. Picomaviruses (Enterovirus & Rhinovirus Groups). Chapter 36 in: Brooks GF, Butel JS, Morse SA (Eds.). Jawetz, Melnick, & Adelberg's Medical Microbiology (21st ed.). New York: Lange Medical Books/ McGraw-Hill, 1998. pp. 444–455.
   Google Scholar
• Lane RJM, Soteriou BA, Zhang H, Archard LC. Enterovirus related metabolic myopathy: A postviral fatigue syndrome. J Neurol Neurosurg Psychiatry 2003;74: 1382–1386.
   PubMed Web of Science ®Google Scholar
• Modlin JF. Coxsackieviruses, echoviruses, and newer enteroviruses. Chapter 149 in: Mandell GL, Bennett JE, Dolin R (Eds.). Principles and Practice of Infectious Diseases (4th ed.). New York: Churchill Livingstone, 1995. pp. 1620–1636.
   Google Scholar
• Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whitton JL. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, patho-genesis, and immunopathology. Virology 2000;271:276–288.
   PubMed Web of Science ®Google Scholar
• Nashef L, Lane RJM. Screening for mitochondria' cytopathies: The suban-aerobic threshold exercise test (SATET). J Neurol Neurosurg Psychiatry 1989;52: 1090–1094.
   PubMed Web of Science ®Google Scholar
• Portney LG, Watkins MP. Correlation. Chapter 23 in: Portney LG, Watkins MP (Eds.). Foundations of Clinical Research: Applications to Practice. (2nd ed.), New Jersey: Prentice Hall Health 2000. pp. 491–508.
   Google Scholar
• Sharpe MC, Archard LC, Banatvala JE et al. A report: Chronic fatigue syn-drome: Guidelines for research. J R Soc Med 1991;84:118–121.
   PubMed Web of Science ®Google Scholar
• Nijs J. Melatonin treatment and phototherapy in patients with chronic fatigue syndrome-Critical reviews and comments on current research. J Chronic Fatigue Syndr 2003;11:69–72.
   Google Scholar
• Fukuda K, Strauss SE, Hickie Jet al. The Chronic Fatigue Syndrome, a compre-hensive approach to its definition and study. Ann Intern Med 1994;121:953–959.
   Google Scholar
• Hickie I, Lloyd A, Wakefield D. Chronic fatigue syndrome: Current perspec-tives on evaluation and management. Med J Aust 1995;163:314–318.
   Google Scholar
• Bates DW, Buchwald D, Lee J et al. A comparison of case definitions of Chronic Fatigue Syndrome. Clin Res 1992;40:434A (Abstract).
   Google Scholar
• Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, Akiya K. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and pri-mary fibromyalgia: A possible marker for hypersomnia and cognitive disorders. Rheumatology 2001;40: 806–810.
   Google Scholar
• Nijs J, De Meirleir K, Truyen S. Hypermobility in patients with chronic fatigue syndrome: Preliminary observations. J Musculosketal Pain 2004;12: 9–17.
   Web of Science ®Google Scholar
• Tan EM, Sugura K, Gupta S. The case definition of chronic fatigue syndrome. J ClM Immunol 2002;22:8–12.
   Google Scholar
• Barrows DM. Functional capacity evaluations of persons with Chronic Fatigue Immune Dysfunction Syndrome. Am J Occup Ther 1995;49:327–337.
   PubMed Web of Science ®Google Scholar
• Donnay A, Ziem G. Prevalence and overlap of chronic fatigue syndrome and fibromyalgia syndrome among 100 new patients with multiple chemical sensitivity syndrome. J Chronic Fatigue Syndr 1999; 5:71–80.
   Google Scholar
• Klimas N. Pathogenesis of chronic fatigue syndrome and fibromyalgia: Re-view. Growth Horm IGF Res 1998;8:123–126.
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuro-immunomodulation 1997;4:134–153.
   PubMed Web of Science ®Google Scholar
• van Middendorp H, Geenen R, Kuis W et al. Psychological adjustment of ado-lescent girls with chronic fatigue syndrome. Pediatrics 2001;107:1–8.
   PubMed Web of Science ®Google Scholar
• Bowles NE, Bayston TA, Zhang HY, Doyle D, Lane RJ, Cunningham L, Archard LC. Persistance of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory myo-pathy. J Med 1993;24:145–160.
   Google Scholar
• Galbraith DN, Nairn C, Clements GB. Evidence for enteroviral persistence in humans. J Gen Virol 1997;78:307–312.
   PubMed Web of Science ®Google Scholar
• Nairn C, Gailbraith DN, Clements GB. Comparison of coxsackie B neutralisa-tion and enteroviral PCR in chronic fatigue syndrome patients. J Med Virol 1995; 46:310–313.
   Google Scholar
• Smith MS, Mitchell J, Corey L, Gold D, McCauley EA, Glover D, Tenover FC. Chronic fatigue in adolescents. Pediatrics 1991;88:195–202.
   Google Scholar
• Milton JD, Clements GB, Edwards RH. Immune responsiveness in chronic fa-tigue syndrome. Potsgrad Med J 1991;67:532–537.
   Google Scholar
• Padalko E, Nuyens D, De Palma A et al. The interferon inducer Ampligen [Poly(I)-Poly(C12U)] markedly protects mice against Coxsackie B3 virus-induced myocarditis. Antimicrob Agents Chemother 2004;48:267–274.
   Google Scholar